Yahoo Web Search

  1. Edited Transcript of MSB.AX earnings conference call or presentation 29-Aug-19 10:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceSep 20 9:43 AM

    This trial has completed patient enrollment with 566 patients randomized to receive either Revascor or placebo across 55 centers in North America. The trial's primary endpoint seeks to ...

  1. Ads
    related to TAKEDA PHARMACEUTICALS AMERICA, INC